| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.11 | 0.08 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.1 | 0.08 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.08 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.053 | 0.08 |